At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Pressure and flow measurement during simulated VT (diagnostic test)
- How long the study runs
- Study runs about 34 months (dates as stated)
- About the drug or intervention
- Pressure and flow measurement during simulated VT — diagnostic test: Participants undergoing coronary angiography will have measurements of blood pressure, coronary pressure and coronary flow during simulated VT.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 70
- Started
- 2023-08-01
- Last checked
- 2026-03
Plain English Summary
What is this study?
- • Testing a new treatment for ventricular tachycardia
- • Clinical study - 70 participants
- • The goal of this observational study is to learn about the factors which determine how well ventricular tachycardia (VT) is tolerated
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with ventricular tachycardia
Where?
- • London - Imperial College NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this observational study is to learn about the factors which determine how well ventricular tachycardia (VT) is tolerated. The main questions it aims to answer are: 1. What impact does coronary artery disease have on the ability for a patient to tolerate VT? 2. Does treatment of coronary artery disease with stents improve the tolerability of VT? Participants who are undergoing a clinically indicated coronary angiogram or coronary angioplasty procedure will have measurements of blood pressure, coronary pressure and coronary flow made during pacing at a range of heart rates.
More detail
Ventricular tachycardia (VT) is a common and life-threatening arrhythmia that occurs in people with heart problems. Some patients who develop this arrhythmia remain very stable with very little symptoms while others become unstable with low blood pressure or even sudden death. It is not known why some people tolerate the arrhythmia well and others do not. If VT is not tolerated then current practice is to offer an implantable cardioverter defibrillator (ICD) which can deliver a shock to the heart if dangerous heart rhythms are detected. While shocks can be life-saving, they are also harmful, including causing psychological distress. ICDs also frequently deliver shocks when they are not needed. If research could identify which factors predispose a person to be stable or unstable in VT, this would allow doctors to help them in a range of ways. One way would be to treat patients to improve the tolerance of VT, so avoiding the need for an ICD. Another would be to assess the the risk of instability and so allow a patient-centred decision on whether an ICD is needed. In this study the investigators plan to recruit patients who are referred for a coronary angiogram. During the angiogram, the investigators will stimulate the heart at a range of fast heart rates and measure their blood pressure and flow in their coronary arteries. In patients who undergo stenting for a coronary stenosis, the investigators will also make these measurements after stenting so they can see if there is any difference. By recruiting a range of different cardiology patients, the investigators will be able to assess which factors contribute to stability during VT.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Able to give valid consent
- ✓Referred for coronary angiography or coronary angioplasty
- ✓Suitable for percutaneous physiological interrogation and PCI when clinically indicated
Who cannot take part
- ✗Unable to give valid consent
- ✗Pregnant or breastfeeding women
- ✗Unstable coronary artery disease (acute coronary syndrome)
- ✗Severe multivessel coronary artery disease suitable for coronary artery bypass grafting
- ✗Severe heart valve disease
See the full criteria
Where Is This Study? (1 UK site)
Imperial College NHS Foundation Trust
London W12 0HS, United Kingdom
How to Get in Touch
Rahul Bahl
Sponsor contactCONTACT
Ricardo Petraco
Sponsor contactCONTACT
